Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenling Li

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Ecotoxicology and Environmental Safety|September 9, 2023
Effects of high manganese-cultivated seedlings on cadmium uptake by various rice (Oryza sativa L.) genotypesGaoxiang Huang, Yunpei Huang, Xinya Ding, et al.
Blood Advances|February 24, 2026
Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencingBaijun Fang, Zunmin Zhu, Yinyin Chang, et al.
Optics Letters|December 24, 2025
High-energy, 3 ps, 1.5 μm optical parametric conversion based on a periodic KTA crystals arrayZhenling Li, Aonan Zhang, Jingya Zhang, et al.
Journal for Immunotherapy of Cancer|September 23, 2024
BCMA-BBZ-OX40 CAR-T Therapy Using an Instant Manufacturing Platform in Multiple MyelomaTing Wang, Yazi Yang, Lie Ma, et al.
Annals of Hematology|March 23, 2026
Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patientsLingli Wang, Jinping Pi, Xiaohui He, et al.
Journal of Neuro-Oncology|March 2, 2026
Real-world comparison of BTK inhibitors and lenalidomide as first-line maintenance in primary CNS lymphoma: a multi-center retrospective studyXiaoli Chang, Zhangyuting He, Huanyuan Wang, et al.
Cancer Medicine|April 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort studyAijun Liu, Hong Yu, Rui Hou, et al.
Leukemia & Lymphoma|June 13, 2022
Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndromeXiaodong Lyu, Tao Li, Dandan Zhu, et al.
Annals of Medicine|March 28, 2025
Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective studyYuan Yang, Ping Yang, Wei Zhang, et al.
Signal Transduction and Targeted Therapy|April 26, 2026
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 studyLin Gui, Haifeng Liu, Huaqing Wang, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Ecotoxicology and Environmental Safety|September 9, 2023
Effects of high manganese-cultivated seedlings on cadmium uptake by various rice (Oryza sativa L.) genotypesGaoxiang Huang, Yunpei Huang, Xinya Ding, et al.
Blood Advances|February 24, 2026
Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencingBaijun Fang, Zunmin Zhu, Yinyin Chang, et al.
Optics Letters|December 24, 2025
High-energy, 3 ps, 1.5 μm optical parametric conversion based on a periodic KTA crystals arrayZhenling Li, Aonan Zhang, Jingya Zhang, et al.
Journal for Immunotherapy of Cancer|September 23, 2024
BCMA-BBZ-OX40 CAR-T Therapy Using an Instant Manufacturing Platform in Multiple MyelomaTing Wang, Yazi Yang, Lie Ma, et al.
Annals of Hematology|March 23, 2026
Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patientsLingli Wang, Jinping Pi, Xiaohui He, et al.
Journal of Neuro-Oncology|March 2, 2026
Real-world comparison of BTK inhibitors and lenalidomide as first-line maintenance in primary CNS lymphoma: a multi-center retrospective studyXiaoli Chang, Zhangyuting He, Huanyuan Wang, et al.
Cancer Medicine|April 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort studyAijun Liu, Hong Yu, Rui Hou, et al.
Leukemia & Lymphoma|June 13, 2022
Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndromeXiaodong Lyu, Tao Li, Dandan Zhu, et al.
Annals of Medicine|March 28, 2025
Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective studyYuan Yang, Ping Yang, Wei Zhang, et al.
Signal Transduction and Targeted Therapy|April 26, 2026
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 studyLin Gui, Haifeng Liu, Huaqing Wang, et al.
Pageof 6